SKYE

Skye Bioscience, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Grayson Paul A.Director
$430k86.2k shares
SellNov 18, 2024
$4.99
--
Grayson Paul A.Director
$1.7k307 shares
SellNov 15, 2024
$5.55
--
Dhillon PunitDirector, Officer: Chief Executive Officer
$412k82.5k shares
SellNov 18, 2024
$4.99
--
Dhillon PunitDirector, Officer: Chief Executive Officer
$2.0k364 shares
SellNov 15, 2024
$5.55
--
Arsenault KaitlynChief Financial Officer
$216k43.2k shares
SellNov 18, 2024
$4.99
--
Arsenault KaitlynChief Financial Officer
$1.1k190 shares
SellNov 15, 2024
$5.55
--

News

globenewswire.comSkye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1globenewswire.comMay 20globenewswire.comUPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Updateglobenewswire.comMay 12globenewswire.comSkye Bioscience Reports First Quarter 2026 Financial Results and Business Updateglobenewswire.comMay 11globenewswire.comKuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firmglobenewswire.comApr 22globenewswire.comSkye Bioscience Presenting at GLP-1-Based Therapeutics Summitglobenewswire.comApr 7